Vol 12, No 2 (2018)
Research paper
Published online: 2018-06-06

open access

Page views 378
Article views/downloads 836
Get Citation

Connect on Social Media

Connect on Social Media

What do students know about the use of opioids in the treatment of chronic cancer-related pain

Monika Rucińska12, Anna Kieszkowska-Grudny3, Anna Sugajska12, Karolina Osowiecka45, Anna Siwy-Hudowska6
Palliat Med Pract 2018;12(2):106-117.

Abstract

Background. Pain occurs in the majority of patients with cancer. Approximately 75% of patients requires administration of opioids. The aim of the study was to evaluate the students’ knowledge about the use of opioids in the treatment of cancer pain.

Material and methods. The study included 167 students in different divisions. The questionnaire prepared for this study was used.

Results. 2/3 of students agreed with the statement that, in the case of chronic pain, opioids used at regular intervals are better than feeding them when pain occurs. 1/4 of respondents thought that before you give another dose of a painkiller, a patient should feel the pain. Students of the medical division more often than students of other divisions gave correct answers to questions about the route of administration and the need to use opioids at regular intervals, without having to wait for pain. More than half of all students believed that increasing doses of painkillers may mean that the patient becomes addicted to opioids. On the question whether it may be useful to provide the placebo for patients with pain in order to assess whether the actually has painful 62% of students sad yes. In both cases, there was no difference between the medical students and the other. In the case of medical students there is a significant difference in the responses provided for the benefit of students of older years.

Conclusions. The knowledge about the treatment of pain, including the use of opioids among young people is insufficient. Medical students of the older years turn out to be better versed on the use of opioids in cancer pain than students of the lower years and other students.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9): 1437–1449.
  2. Sun VCY, Borneman T, Ferrell B, et al. Overcoming barriers to cancer pain management: an institutional change model. J Pain Symptom Manage. 2007; 34(4): 359–369.
  3. Cancer Pain Relief. World Health Organization. Geneva, Switzerland, 1996.
  4. Wiffen PJ, Derry S, Moore RA, et al. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2013; 4(7): CD003868.
  5. Ripamonti CI, Santini D, Maranzano E, et al. ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2012; 23 Suppl 7: vii139–vii154.
  6. Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017; 7: CD012592.
  7. Turner BJ, Liang Y, Rodriguez N, et al. Gaps in the Public's Knowledge About Chronic Pain: Representative Sample of Hispanic Residents From 5 States. J Pain. 2017; 18(6): 628–636.
  8. Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008; 19(12): 1985–1991.
  9. Apolone G, Corli O, Caraceni A, et al. Cancer Pain Outcome Research Study Group (CPOR SG) Investigators. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer. 2009; 100(10): 1566–1574.
  10. Goldberg DS. On the erroneous conflation of opiophobia and the undertreatment of pain. Am J Bioeth. 2010; 10(11): 20–22.
  11. Reid CM, Gooberman-Hill R, Hanks GW. Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Ann Oncol. 2008; 19(1): 44–48.
  12. Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med. 1996; 335(3): 172–178.
  13. Bercovitch M, Adunsky A. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it? Cancer. 2004; 101(6): 1473–1477.
  14. Fohr SA. The double effect of pain medication: separating myth from reality. J Palliat Med. 1998; 1(4): 315–328.
  15. Jage J. Opioid tolerance and dependence -- do they matter? Eur J Pain. 2005; 9(2): 157–162.
  16. Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011; 30(3): 300–305.
  17. Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain. 2007; 11(5): 490–518.
  18. Lema MJA. A compassionate approach to pain management in the terminally ill patient. Hospital Medicine. 1998; 34: 11–21.
  19. Bennett DS, Carr DB. Opiophobia as a barrier to the treatment of pain. J Pain Palliat Care Pharmacother. 2002; 16(1): 105–109.
  20. Sykes N, Thorns A. The use of opioids and sedatives at the end of life. The Lancet Oncology. 2003; 4(5): 312–318.



Palliative Medicine in Practice